Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy
NCT00606827 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2012-05-08
Summary
Contrast-induced nephrophaty (CIN) accounts for more than 10% of hospital-acquired renal failure. Hydration with sodium bicarbonate is more protective than isotonic saline in animals. Limited data are available in humans. We compared the efficacy of sodium bicarbonate versus isotonic saline to prevent CIN in a large population of patients with renal dysfunction undergoing coronary angiography or intervention.
Conditions
- Contrast-Induced Nephropathy
Interventions
- DRUG
-
Sodium Bicarbonate
Patients in the sodium bicarbonate group (154 mEq/L) received 3 ml/kg for 1 hour before contrast medium, followed by an infusion of 1 ml/kg/h for 6 hours after the procedure
- DRUG
-
Isotonic Saline
Patients assigned to the isotonic saline group received 1 ml/kg/h 0.9% sodium chloride for 12 hours before and after the procedure
Sponsors & Collaborators
-
Ospedale Misericordia e Dolce
lead OTHER
Principal Investigators
-
Mauro Maioli, MD · Cardiology Unit - Prato
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Completion
- 2006-03-31
Countries
- Italy
Study Locations
More Related Trials
-
Hydration and Contrast-Induced Nephropathy in Primary Angioplasty
NCT00770614 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
NCT01093131 ·Status: WITHDRAWN ·Phase: PHASE4
-
Early Hydration in Acute Myocardial Infarction
NCT01742130 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.
NCT00639912 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection
NCT00700375 ·Status: COMPLETED ·Phase: PHASE4
-
Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN)
NCT00749827 ·Status: WITHDRAWN ·Phase: PHASE4
-
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy
NCT01172353 ·Status: COMPLETED ·Phase: PHASE3
-
Does Bicarbonate in Addition to Theophylline Reduce CIN?
NCT02643602 ·Status: COMPLETED ·Phase: NA
-
Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury
NCT01612013 ·Status: COMPLETED ·Phase: NA
-
Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography
NCT00950079 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine
NCT00353340 ·Status: COMPLETED ·Phase: NA
-
PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION
NCT00130598 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
NCT00716001 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
NCT00930436 ·Status: TERMINATED ·Phase: PHASE3
-
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
NCT03627130 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
NCT00424320 ·Status: UNKNOWN ·Phase: PHASE3
-
COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT
NCT00497328 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
NCT00312117 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
NCT00579995 ·Status: TERMINATED ·Phase: NA
-
Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN
NCT02718521 ·Status: UNKNOWN ·Phase: NA
-
Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration
NCT01786824 ·Status: TERMINATED ·Phase: PHASE3
-
A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in Croatia
NCT02761577 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate
NCT00540904 ·Status: COMPLETED ·Phase: PHASE2
-
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
NCT03627884 ·Status: COMPLETED ·Phase: PHASE4